Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125807021 | 12580702 | 1 | I | 20160102 | 20160711 | 20160721 | 20160721 | EXP | GB-MHRA-EYC 00142056 | GB-WATSON-2016-15724 | WATSON | 57.00 | YR | M | Y | 103.00000 | KG | 20160721 | CN | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125807021 | 12580702 | 1 | PS | FLUOXETINE | FLUOXETINE HYDROCHLORIDE | 1 | Oral | 20 MG, UNKNOWN | Y | UNCONFIRMED | 75662 | 20 | MG | UNK | |||||
| 125807021 | 12580702 | 2 | C | ALLOPURINOL. | ALLOPURINOL | 1 | Unknown | UNK | U | 0 | |||||||||
| 125807021 | 12580702 | 3 | C | ATORVASTATIN | ATORVASTATIN | 1 | Unknown | UNK | U | 0 | |||||||||
| 125807021 | 12580702 | 4 | C | BISOPROLOL | BISOPROLOL | 1 | Unknown | UNK | U | 0 | |||||||||
| 125807021 | 12580702 | 5 | C | GLICLAZIDE | GLICLAZIDE | 1 | Unknown | UNK | U | 0 | |||||||||
| 125807021 | 12580702 | 6 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Unknown | UNK | U | 0 | |||||||||
| 125807021 | 12580702 | 7 | C | RAMIPRIL. | RAMIPRIL | 1 | Unknown | UNK | U | 0 | |||||||||
| 125807021 | 12580702 | 8 | C | SITAGLIPTIN | SITAGLIPTIN | 1 | Unknown | UNK | U | 0 | |||||||||
| 125807021 | 12580702 | 9 | C | SLOZEM | DILTIAZEM | 1 | Unknown | UNK | U | 0 | |||||||||
| 125807021 | 12580702 | 10 | C | WARFARIN | WARFARIN | 1 | Unknown | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125807021 | 12580702 | 1 | Anxiety |
| 125807021 | 12580702 | 2 | Product used for unknown indication |
| 125807021 | 12580702 | 3 | Product used for unknown indication |
| 125807021 | 12580702 | 4 | Product used for unknown indication |
| 125807021 | 12580702 | 5 | Product used for unknown indication |
| 125807021 | 12580702 | 6 | Product used for unknown indication |
| 125807021 | 12580702 | 7 | Product used for unknown indication |
| 125807021 | 12580702 | 8 | Product used for unknown indication |
| 125807021 | 12580702 | 9 | Product used for unknown indication |
| 125807021 | 12580702 | 10 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125807021 | 12580702 | HO |
| 125807021 | 12580702 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125807021 | 12580702 | Blindness unilateral | |
| 125807021 | 12580702 | Feeling abnormal | |
| 125807021 | 12580702 | Headache | |
| 125807021 | 12580702 | Hemianopia homonymous | |
| 125807021 | 12580702 | Reversible cerebral vasoconstriction syndrome | |
| 125807021 | 12580702 | Visual impairment |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125807021 | 12580702 | 1 | 20151120 | 20160114 | 0 |